We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
-5.17%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$6.16B
AUM Growth
-$821M
Cap. Flow
-$392M
Cap. Flow %
-6.36%
Top 10 Hldgs %
16.27%
Holding
911
New
217
Increased
113
Reduced
100
Closed
202

Top Buys

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$100M
2
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
+$97M
3
LRCX icon
Lam Research
LRCX
+$85.4M
4
BSX icon
Boston Scientific
BSX
+$79.4M
5
MRK icon
Merck
MRK
+$67M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$145M
2
ASML icon
ASML
ASML
+$119M
3
QRVO icon
Qorvo
QRVO
+$89M
4
MSFT icon
Microsoft
MSFT
+$82.9M
5
ISRG icon
Intuitive Surgical
ISRG
+$75.5M

Sector Composition

Rank Sector Weight
1 Healthcare 38.56%
2 Technology 29.01%
3 Industrials 8.79%
4 Communication Services 5.99%
5 Financials 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNDA
326
DELISTED
Concord Acquisition Corp II
CNDA
$2.9M 0.05%
300,000
– –
LUNR icon
327
Intuitive Machines
LUNR
$2.4B
$2.9M 0.05%
300,000
– –
TJX icon
328
TJX Companies
TJX
$179B
$2.9M 0.05%
+47,816
New +$3.2M
HWEL
329
DELISTED
Healthwell Acquisition Corp. I Class A Common Stock
HWEL
$2.9M 0.05%
300,000
– –
THRX
330
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$2.88M 0.05%
250,000
– –
CPUH
331
DELISTED
Compute Health Acquisition Corp.
CPUH
$2.87M 0.05%
293,553
– –
TYRA icon
332
Tyra Biosciences
TYRA
$1.61B
$2.85M 0.05%
266,161
+1,416
+0.5% +$16.8K
AAC
333
DELISTED
Ares Acquisition Corporation
AAC
$2.81M 0.05%
286,666
– –
ONEM
334
DELISTED
1Life Healthcare
ONEM
$2.8M 0.05%
252,624
-54,446
-18% -$610K
GSQD
335
DELISTED
G Squared Ascend I Inc.
GSQD
$2.73M 0.04%
277,511
– –
SCAQ
336
DELISTED
Stratim Cloud Acquisition Corp. Class A Common Stock
SCAQ
$2.68M 0.04%
275,000
– –
TSPQ
337
DELISTED
TCW Special Purpose Acquisition Corp.
TSPQ
$2.68M 0.04%
275,000
– –
EBAC
338
DELISTED
European Biotech Acquisition Corp. Class A Ordinary Shares
EBAC
$2.68M 0.04%
275,000
– –
LONA
339
LeonaBio Inc
LONA
$73.4M
$2.67M 0.04%
+19,759
New +$2.08M
ELDN icon
340
Eledon Pharmaceuticals
ELDN
$267M
$2.65M 0.04%
673,138
-108,238
-14% -$420K
GOSS icon
341
Gossamer Bio
GOSS
$87.2M
$2.64M 0.04%
304,029
-673,794
-69% -$6.5M
IPSC icon
342
Century Therapeutics
IPSC
$343M
$2.62M 0.04%
208,082
– –
MDRX
343
DELISTED
Veradigm Inc. Common Stock
MDRX
$2.59M 0.04%
+114,941
New +$2.33M
SAGE
344
DELISTED
Sage Therapeutics
SAGE
$2.58M 0.04%
+77,866
New +$2.93M
HRT
345
DELISTED
HireRight Holdings Corporation
HRT
$2.56M 0.04%
150,000
– –
IMTX icon
346
Immatics
IMTX
$1.29B
$2.55M 0.04%
319,480
-424,010
-57% -$3.86M
MBAC
347
DELISTED
M3-Brigade Acquisition II Corp.
MBAC
$2.54M 0.04%
259,819
– –
TGR.U
348
DELISTED
Kimbell Tiger Acquisition Corporation Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant
TGR.U
$2.53M 0.04%
+250,000
New +$2.52M
SPCMU
349
DELISTED
Sound Point Acquisition Corp I, Ltd Unit
SPCMU
$2.52M 0.04%
+250,000
New +$2.51M
SIEN
350
DELISTED
Sientra, Inc.
SIEN
$2.48M 0.04%
111,760
-5,100
-4% -$140K
12 13
14
15 16

Similar funds

TCIIS
TIAA-CREF Individual & Institutional Services New York $26B AUM
WorldQuant Millennium Advisors
WorldQuant Millennium Advisors New York $25.9B AUM 22.07% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $27B AUM 24.49% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return
VAI
Vanguard Advisers Inc Malvern, Pennsylvania $25.5B AUM
KK
KLP Kapitalforvaltning Oslo, Norway $25.5B AUM 28.18% 1-Year Est. Return

Woodline Partners's Q1 2022 Portfolio in Review

As of Q1 2022, Woodline Partners held 911 positions worth $6.16B, down 12% from $6.98B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Woodline Partners withdrew a net $392M in Q1 2022, closing 202 positions and reducing 100 holdings. Its most notable exit was AbbVie, an estimated $145M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 41% a quarter earlier, followed by Technology and Industrials.

Against the trend, Woodline Partners opened a new position in ZYNGA INC. CL A COMMON worth $102M.

  • Woodline Partners's largest Q1 2022 buy was ZYNGA INC. CL A COMMON: 11,039,458 shares worth $102M.
  • Woodline Partners added most to Seagen Inc. Common Stock in Q1 2022, an estimated $100M increase.
  • Woodline Partners's biggest Q1 2022 reduction was Qorvo, cutting an estimated $89M.
  • Woodline Partners fully exited AbbVie in Q1 2022, selling an estimated $145M.
  • Woodline Partners's ten largest holdings make up 16% of its $6.16B portfolio in Q1 2022.
  • Woodline Partners opened 217 new positions and closed 202 in Q1 2022.
  • Woodline Partners's portfolio value fell 12% quarter-over-quarter to $6.16B.

Based on Woodline Partners's 13F filing for Q1 2022, filed 16 May 2022.